biogazelle-logo-white
  • COVID-19
  • Solutions
    • RNA sequencing
    • HTPathwaySeq
    • HTTargetSeq
    • Digital PCR
    • Quantitative PCR
    • Custom primer design
    • Gene expression analysis
    • Mutation detection
    • Copy number analysis
    • SNP genotyping
    • Fusion gene detection
    • Antisense oligonucleotide screening
    • Sample preparation
  • Expertise
    • Biomarker discovery
    • Biomarker test development
    • Diagnostic services
    • Adoptive cell therapies
    • Non-coding RNA
    • Liquid biopsies
    • Clinical trials
    • Data analysis
  • Knowledge center
  • Publications
  • About
    • Contact
    • News & Events
      • News
      • Events
    • Why Biogazelle
    • Vision & mission
    • Management
    • Board of directors
    • Quality management
    • Our partners
    • Careers
biogazelle-logo
  • COVID-19
  • Solutions
    • RNA sequencing
    • HTPathwaySeq
    • HTTargetSeq
    • Digital PCR
    • Quantitative PCR
    • Custom primer design
    • Gene expression analysis
    • Mutation detection
    • Copy number analysis
    • SNP genotyping
    • Fusion gene detection
    • Antisense oligonucleotide screening
    • Sample preparation
  • Expertise
    • Biomarker discovery
    • Biomarker test development
    • Diagnostic services
    • Adoptive cell therapies
    • Non-coding RNA
    • Liquid biopsies
    • Clinical trials
    • Data analysis
  • Knowledge center
  • Publications
  • About
    • Contact
    • News & Events
      • News
      • Events
    • Why Biogazelle
    • Vision & mission
    • Management
    • Board of directors
    • Quality management
    • Our partners
    • Careers
biogazelle-logo
  • COVID-19
  • Solutions
    • RNA sequencing
    • HTPathwaySeq
    • HTTargetSeq
    • Digital PCR
    • Quantitative PCR
    • Custom primer design
    • Gene expression analysis
    • Mutation detection
    • Copy number analysis
    • SNP genotyping
    • Fusion gene detection
    • Antisense oligonucleotide screening
    • Sample preparation
  • Expertise
    • Biomarker discovery
    • Biomarker test development
    • Diagnostic services
    • Adoptive cell therapies
    • Non-coding RNA
    • Liquid biopsies
    • Clinical trials
    • Data analysis
  • Knowledge center
  • Publications
  • About
    • Contact
    • News & Events
      • News
      • Events
    • Why Biogazelle
    • Vision & mission
    • Management
    • Board of directors
    • Quality management
    • Our partners
    • Careers
Menu
  • COVID-19
  • Solutions
    • RNA sequencing
    • HTPathwaySeq
    • HTTargetSeq
    • Digital PCR
    • Quantitative PCR
    • Custom primer design
    • Gene expression analysis
    • Mutation detection
    • Copy number analysis
    • SNP genotyping
    • Fusion gene detection
    • Antisense oligonucleotide screening
    • Sample preparation
  • Expertise
    • Biomarker discovery
    • Biomarker test development
    • Diagnostic services
    • Adoptive cell therapies
    • Non-coding RNA
    • Liquid biopsies
    • Clinical trials
    • Data analysis
  • Knowledge center
  • Publications
  • About
    • Contact
    • News & Events
      • News
      • Events
    • Why Biogazelle
    • Vision & mission
    • Management
    • Board of directors
    • Quality management
    • Our partners
    • Careers

  • Case Study (8)
  • Tech Note (7)
  • Video (6)
  • Poster (5)
  • Presentation (3)
  • Article (2)
Presentation

Introduction to HTPathwaySeq

February 11, 2020
Presentation

Introduction to HTTargetSeq

February 11, 2020
Presentation

Exploiting tumor RNA seq data for prediction of immune checkpoint inhibition through TMB & MSI assessment

November 21, 2019

Subscribe to email updates 

Biogazelle

Technologiepark 82
B-9052 Zwijnaarde
Belgium

email: info@biogazelle.com
phone: +32 9 245 96 43
fax: +32 9 251 56 56

Menu

  • • Services
  • • Expertise
  • • Knowledge center
  • • Publications
  • • News
  • • Events
  • • About
  • • Contact

Contact us

Copyright © 2021 Biogazelle. All Rights Reserved. - Privacy Policy